Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Parasite clearance on Days 2 and 3 of treatment

From: In vivo efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo

  ASAQ AL p value
Patients with parasite positivity at D2 18 (13.7 %) 27 (20.0 %) 0.173
Patients with parasite positivity at D3 2 (1.5 %) 6 (4.4 %) 0.167